Genomma Lab named an interim CEO. Genomma Lab stock fell 1.56 percent.

Published on 10/08/2026 at 16:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genomma Lab stock costs EUR 0.63 on October 8, 2026 after EUR 0.64, down 1.56 percent. Second-quarter revenue rose 4.93 percent to MXN 4,397.04 million.

Key points in brief

Das Wichtigste in Kürze

Genomma Lab named founder Rodrigo Herrera Aspra interim CEO effective January 1, 2027, with a 12 to 18-month mandate.
Second-quarter revenue rose 4.93 percent quarter over quarter to MXN 4,397.04 million, while net income fell 24.29 percent to MXN 374.49 million.
Genomma Lab stock was trading at EUR 0.63 at Lang & Schwarz on October 8, 2026, down 1.56 percent versus the EUR 0.64 prior close.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab (ISIN MX01LA010006) was trading at EUR 0.63 at Lang & Schwarz on October 8, 2026 at 4:08 p.m. CEST, down 1.56 percent versus the EUR 0.64 prior close. The company had named founder Rodrigo Herrera Aspra interim Chief Executive Officer on September 17, 2026, effective January 1, 2027, according to PR Newswire.

What changes on January 1?

Herrera is expected to serve for 12 to 18 months while Genomma Lab implements a new operating model and searches for a permanent successor. PR Newswire reported on September 17, 2026 that the model will use artificial intelligence agents across marketing, sales, supply and finance.

The transition has a defined operating horizon rather than an open-ended leadership change. The release also said the model had been tested with Suerox Mineral and would be extended across Genomma Lab's portfolio and 18 countries, giving the management shift a measurable execution target.

What does the latest quarter show?

In the second quarter of 2026, revenue rose 4.93 percent quarter over quarter from MXN 4,190.62 million to MXN 4,397.04 million, while net income fell 24.29 percent from MXN 494.65 million to MXN 374.49 million, according to Investing.com. The revenue increase and profit decline point to a mixed operating picture heading into the leadership transition.

Genomma Lab's recent chronology

On July 23, 2026, the second-quarter release showed MXN 4,397.04 million in revenue and MXN 374.49 million in net income. On September 17, 2026, the company announced Herrera's interim CEO appointment for January 1, 2027 and a 12 to 18-month mandate. On October 1, 2026, Genomma Lab announced that its third-quarter results would be released on October 21, 2026, according to Yahoo Finance.

Upcoming dates for Genomma Lab

The next two scheduled events are the third-quarter results release on October 21, 2026, and the earnings conference call on October 22, 2026 at 11:00 a.m. Mexico City time, as reported by Yahoo Finance. The December 3, 2026 Genomma Day is also scheduled in New York, where the company plans to present the operating model.

Genomma Lab stock sets the reference point

At Lang & Schwarz, Genomma Lab stock was trading at EUR 0.63 on October 8, 2026 at 4:08 p.m. CEST, down 1.56 percent versus the EUR 0.64 prior close of October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.